FierceBiotechOriginal article
{"a":[{"_":"GSK aiming to ‘balance West and East’ after Hansoh deal success showed China’s potential","$":{"href":"/biotech/gsk-trying-balance-east-and-west-hansoh-deal-success-showed-chinas-potential","hreflang":"en"}}]}
PartnershipPositive
AI Analysis
Summary
GSK is implementing a strategy to balance its West and East operations following the success of its Hansoh deal, which demonstrated the potential of licensing drugs from China.
Importance:4/10
Sentiment:
0.50
licensingChinastrategypartnership
Read the original article
Published by FierceBiotech on September 22, 2026 1:59 PM
